[Latest diagnostic methods in fields outside of otorhinolaryngology: current status and overview of individualized therapy using companion diagnostic drugs and molecular targeting drugs for the management of breast cancer].
Jun
J
Hashimoto
Kenji
K
Tamura
Yasuhiro
Y
Fujiwra
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D057285:Precision Medicine; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab
D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human